Effects of inductive bias on computational evaluations of ligand-based modeling and on drug discovery

被引:0
|
作者
Ann E. Cleves
Ajay N. Jain
机构
[1] BioPharmics LLC,
[2] University of California,undefined
[3] San Francisco,undefined
关键词
Inductive bias; Ligand-based modeling; Computational evaluation; Molecular similarity; Surflex-Sim;
D O I
暂无
中图分类号
学科分类号
摘要
Inductive bias is the set of assumptions that a person or procedure makes in making a prediction based on data. Different methods for ligand-based predictive modeling have different inductive biases, with a particularly sharp contrast between 2D and 3D similarity methods. A unique aspect of ligand design is that the data that exist to test methodology have been largely man-made, and that this process of design involves prediction. By analyzing the molecular similarities of known drugs, we show that the inductive bias of the historic drug discovery process has a very strong 2D bias. In studying the performance of ligand-based modeling methods, it is critical to account for this issue in dataset preparation, use of computational controls, and in the interpretation of results. We propose specific strategies to explicitly address the problems posed by inductive bias considerations.
引用
收藏
页码:147 / 159
页数:12
相关论文
共 50 条
  • [1] Effects of inductive bias on computational evaluations of ligand-based modeling and on drug discovery
    Cleves, Ann E.
    Jain, Ajay N.
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2008, 22 (3-4) : 147 - 159
  • [2] Theoretical and computational approaches to ligand-based drug discovery
    Favia, Angelo D.
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2011, 16 : 1276 - 1290
  • [3] The power of deep learning to ligand-based novel drug discovery
    Baskin, Igor I.
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2020, 15 (07) : 755 - 764
  • [4] Deep Learning for Ligand-Based Virtual Screening in Drug Discovery
    Bahi, Meriem
    Batouche, Mohamed
    [J]. 2018 3RD INTERNATIONAL CONFERENCE ON PATTERN ANALYSIS AND INTELLIGENT SYSTEMS (PAIS), 2018, : 268 - 272
  • [5] Streamlining Computational Fragment-Based Drug Discovery through Evolutionary Optimization Informed by Ligand-Based Virtual Prescreening
    Chandraghatgi, Rohan
    Ji, Hai-Feng
    Rosen, Gail L.
    Sokhansanj, Bahrad A.
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2024, 64 (09) : 3826 - 3840
  • [6] Reducing the bias in ligand-based modelling
    Duffy, Nigel
    Dolin, Brad
    Feng, Yuanjian
    Yu, Jessen
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [7] Integrating structure-based and ligand-based approaches for computational drug design
    Wilson, Gregory L.
    Lill, Markus A.
    [J]. FUTURE MEDICINAL CHEMISTRY, 2011, 3 (06) : 735 - 750
  • [8] Ligand-based drug discovery against RNA using mass spectrometry.
    Swayze, EE
    Hofstadler, SA
    Lowery, K
    Drader, J
    Jefferson, EA
    Osgood, S
    Ding, YL
    Sprankle, KG
    Griffey, RH
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U38 - U38
  • [9] Ligand-Based Approach for Multi-Target Drug Discovery: PTML Modeling of Triple-Target Inhibitors
    Kleandrova, Valeria V.
    Dias Soeiro, Maria Natalia
    Speck-Planche, Alejandro
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2024,
  • [10] Discovery of novel Myc inhibitors using structure and ligand-based drug design
    Liosi, Maria-Elena
    Stellas, Dimitris
    Efstratiadis, Argiris
    Cournia, Zoe
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251